Sera Prognostics, Inc., (SERA): Price and Financial Metrics
SERA Price/Volume Stats
| Current price | $6.03 | 52-week high | $12.35 |
| Prev. close | $6.18 | 52-week low | $1.80 |
| Day low | $5.91 | Volume | 77,800 |
| Day high | $6.34 | Avg. volume | 173,319 |
| 50-day MA | $7.28 | Dividend yield | N/A |
| 200-day MA | $8.09 | Market Cap | 203.65M |
SERA Stock Price Chart Interactive Chart >
Sera Prognostics, Inc., (SERA) Company Bio
Sera Prognostics, Inc., a health diagnostic company, discovers, develops, and commercializes biomarker tests for the early prediction of preterm birth risk and other complications of pregnancy. It develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
SERA Price Returns
| 1-mo | -14.71% |
| 3-mo | -18.84% |
| 6-mo | -30.29% |
| 1-year | 220.74% |
| 3-year | -44.11% |
| 5-year | N/A |
| YTD | 0.84% |
| 2023 | 374.60% |
| 2022 | -81.66% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...